Biotech Values

[swampboots]

Although Shamans need apply and are equally eligible to make abscopal treatments (by their recommendation) more "charismatic", data mining will eventually be piling up to measure the effectiveness of the abscopal effect. :

"Whereas these reports were extremely rare throughout the 20th century, the clinical use of immune checkpoint blocking antibodies such as ipilimumab or pembrolizumab has greatly increased the number of abscopally responding patients in selected groups of patients such as those with metastatic melanoma" (from Wikipedia).